SCHEMBL13176359

SCHEMBL13176359

CCCCCCCCCCCCCCCCN1C(=O)c2ccc3c4c(ccc(c24)C1=O)C(=O)N(CCCCCCCCCCCCCCCC)C3=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.65
▸ MEN1 O00255 2/20 0.65
▸ RGS12 O14924 2/20 0.65
▸ HTT P42858 2/20 0.65
▸ KMT2A Q03164 2/20 0.65
▸ KDM4E B2RXH2 1/20 0.65
▸ NPC1 O15118 1/20 0.65
▸ LMNA P02545 1/20 0.65
▸ PABPC1 P11940 1/20 0.65
▸ RECQL P46063 1/20 0.65
▸ RAB9A P51151 1/20 0.65
▸ SMN1; SMN2 Q16637 1/20 0.65
▸ TERT O14746 5/20 0.61
▸ PTGS1 P23219 3/20 0.55
▸ PTGS2 P35354 3/20 0.55
▸ MGLL Q99685 3/20 0.55
▸ FAAH O00519 1/20 0.55
▸ CES1 P23141 2/20 0.54
▸ CDC25A P30304 1/20 0.54
▸ STAT3 P40763 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL822756 1.00 ALDH1A1 (0.65) ALDH1A1MEN1RGS12HTTKMT2A
SCHEMBL14075775 1.00 ALDH1A1 (0.65) ALDH1A1MEN1RGS12HTTKMT2A
SCHEMBL12132257 1.00 ALDH1A1 (0.65) ALDH1A1MEN1RGS12HTTKMT2A
SCHEMBL7484669 1.00 ALDH1A1 (0.65) ALDH1A1MEN1RGS12HTTKMT2A
SCHEMBL14156552 0.96 MEN1 (0.65) ALDH1A1MEN1RGS12HTTKMT2A
SCHEMBL13259581 0.95 MEN1 (0.59) ALDH1A1MEN1RGS12HTTKMT2A
SCHEMBL13259600 0.95 MEN1 (0.59) ALDH1A1MEN1RGS12HTTKMT2A
SCHEMBL18379137 0.93 STAT3 (0.65) ALDH1A1MEN1RGS12HTTKMT2A
SCHEMBL8071104 0.93 STAT3 (0.65) ALDH1A1MEN1RGS12HTTKMT2A
SCHEMBL418871 0.93 STAT3 (0.65) ALDH1A1MEN1RGS12HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8404705-B2 Naphthalene amidine imides BASF SE (DE) 2013-03-26 — — US disclosed
US-8404705-B2 Naphthalene amidine imides BASF SE (DE) 2013-03-26 — — US disclosed
EP-1907484-B1 NAPHTHALENE AMIDINE IMIDES BASF SE (DE) 2010-09-29 — — EP disclosed
US-20100202984-A1 Naphthalene amidine imides BASF SE (DE) 2010-08-12 — — US disclosed
US-20100202984-A1 Naphthalene amidine imides BASF SE (DE) 2010-08-12 — — US disclosed
WO-2007012611-A1 NAPHTHALENE AMIDINE IMIDES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2007-02-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100202984-A1 Naphthalene amidine imides NES, TXN2, NAT1 ALDH1A1 1047/4885MEN1 130/4885RGS12 4127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback